We conclude our interview with John Kilgour, where we discuss the specialty pharmaceutical market and what systems need to be put in place to ensure success. Fill out the form below to access part one of this exclusive and informative conversation.
Watch now
The impact of DSCSA and role of emerging technology
In part two of this two-part exclusive interview, we chat with pharmaceutical expert, John Kilgour, about technology that can help the specialty pharmaceutical supply chain and how expanding government regulations will come into play.
Did you miss part one of this series? Tune in here.
